Pharming Group N.V.
Pharming Group N.V., a biopharmaceutical company headquartered in the Netherlands, is at the forefront of developing innovative therapies for rare diseases. Founded in 1988, Pharming has achieved significant milestones, including the successful launch of its flagship product, Ruconest, which is used to treat hereditary angioedema. With a strong focus on protein replacement therapies, Pharming operates primarily in Europe and North America, positioning itself as a leader in the biopharmaceutical industry. The company is dedicated to addressing unmet medical needs through its unique recombinant technology, which sets its products apart in the market. Notably, Pharming has garnered recognition for its commitment to research and development, solidifying its reputation as a key player in the field of rare disease treatment.
DitchCarbon Score
How does Pharming Group N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharming Group N.V.'s score of 18 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharming Group N.V.'s reported carbon emissions
Pharming Group N.V., headquartered in the Netherlands, currently does not have publicly available data on its carbon emissions, as there are no reported figures for emissions in kg CO2e. Additionally, the company has not outlined specific reduction targets or commitments related to climate action. In the absence of concrete emissions data or defined climate initiatives, it is unclear how Pharming Group N.V. is addressing its environmental impact. As the industry increasingly prioritises sustainability, it will be essential for Pharming to establish and communicate its climate commitments to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharming Group N.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
